Abstract:A typical neuron consists of a soma, a single axon with numerous nerve terminals, and multiple dendritic trunks with numerous branches. Each of the 100 billion neurons in the brain has on average 7,000 synaptic connections to other neurons. The neuronal endolysosomal compartments for the degradation of axonal and dendritic waste are located in the soma region. That means that all autophagosomal and endosomal cargos from 7,000 synaptic connections must be transported to the soma region for degradation. For that reason, neuronal endolysosomal degradation is an extraordinarily demanding and dynamic event, and thus is highly susceptible to many pathological conditions. Dysfunction in the endolysosomal trafficking pathways occurs in virtually all neurodegenerative diseases. Most lysosomal storage disorders (LSDs) with defects in the endolysosomal system preferentially affect the central nervous system (CNS). Recently, significant progress has been made in understanding the role that the endolysosomal trafficking pathways play after brain ischemia. Brain ischemia damages the membrane fusion machinery co-operated by N-ethylmaleimide sensitive factor (NSF), soluble NSF attachment protein (SNAP), and soluble NSF attachment protein receptors (SNAREs), thus interrupting the membrane-to-membrane fusion between the late endosome and terminal lysosome. This interruption obstructs all incoming traffic. Consequently, both the size and number of endolysosomal structures, autophagosomes, early endosomes, and intra-neuronal protein aggregates are increased extensively in post-ischemic neurons. This cascade of events eventually damages the endolysosomal structures to release hydrolases leading to ischemic brain injury. Gene knockout and selective inhibition of key endolysosomal cathepsins protects the brain from ischemic injury. This review aims to provide an update of the current knowledge, future research directions, and the clinical implications regarding the critical role of the neuronal endolysosomal trafficking pathways in ischemic brain injury.

Mechanisms of lysosomal proteases participating in cerebral ischemia-induced neuronal death

The role of neuronal autophagy in hypoxic-ischemic brain injiny

Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by global cerebral ischemia/reperfusion injury in rats.

Neuronal Injury in Rat Model of Permanent Focal Cerebral Ischemia is Associated with Activation of Autophagic and Lysosomal Pathways.

Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications

Molecular mechanisms of cerebral ischemia-induced neuronal death.

The Role of Ubiquitin-Proteasome Pathway and Autophagy-Lysosome Pathway in Cerebral Ischemia

Regulated necrosis pathways: a potential target for ischemic stroke

Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke

Cell Death Mechanisms in Cerebral Ischemia–Reperfusion Injury

Necroptosis Signaling Pathways in Stroke: from Mechanisms to Therapies

The role of lysosomal rupture in neuronal death

Mitochondrial Fusion and Fission in Neuronal Death Induced by Cerebral Ischemia-Reperfusion and Its Clinical Application: A Mini-Review

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

The Role of Autophagic and Lysosomal Pathways in Ischemic Brain Injury.

The Role of Necroptosis in Cerebral Ischemic Stroke

Necroptosis Signaling Pathways in Stroke: from Mechanisms to Therapies.

The underlying mechanism of calcium toxicity-induced autophagic cell death and lysosomal degradation in early stage of cerebral ischemia

Lysophosphatidic Acid Induces Neuronal Cell Death Via Activation of Asparagine Endopeptidase in Cerebral Ischemia-Reperfusion Injury.

Interruption of Endolysosomal Trafficking After Focal Brain Ischemia